Fletcher Payne
Insider
First SEC filing: Jan. 16, 2018 · Latest: Jan. 16, 2018
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 12, 2019 | GYRE | A | 1,180 | $6.51 | $7,682 | 3,744 Direct | +46.02% | Acquired | -92.7% (price as of 2026-10-02) |
| Feb. 11, 2019 | GYRE | A | 1,002 | $7.04 | $7,054 | 3,731 Direct | +36.72% | Acquired | -93.3% (price as of 2026-10-02) |
| Feb. 4, 2019 | GYRE | M | 1,503 | · | · | 73,497 Direct | -2.00% | Disposed | (price as of 2026-10-02) |
| Feb. 4, 2019 | GYRE | M | 1,503 | $4.63 | $6,959 | 3,230 Direct | +87.03% | Acquired | -89.8% (price as of 2026-10-02) |
| Jan. 24, 2019 | GYRE | A | 38,000 | · | · | 38,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 30, 2018 | GYRE | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 26, 2018 | GYRE | M | 59 | · | · | 74,941 Direct | -0.08% | Disposed | (price as of 2026-10-02) |
| March 26, 2018 | GYRE | M | 59 | $4.63 | $273 | 59 Direct | · | Acquired | -89.8% (price as of 2026-10-02) |
| Jan. 12, 2018 | GYRE | A | 26,000 | · | · | 26,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 11, 2017 | GYRE | A | 75,000 | · | · | 75,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 17, 2015 | GYRE | P | 10,000 | $2.00 | $20,000 | 25,032 Indirect | +66.52% | Acquired | -98.4% (price as of 2026-10-02) |
| Oct. 22, 2015 | GYRE | A | 28,572 | · | · | 28,572 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 22, 2015 | GYRE | A | 71,428 | · | · | 71,428 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 22, 2015 | GYRE | A | 28,572 | · | · | 28,572 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 20, 2015 | GYRE | J | 14,325 | · | · | 14,325 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 20, 2015 | GYRE | J | 2,440 | · | · | 2,440 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 20, 2015 | GYRE | J | 7,320 | · | · | 7,320 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 20, 2015 | GYRE | J | 15,032 | · | · | 15,032 Indirect | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 4, 2019 | GYRE | Stock Option (Right to Buy) | Common Stock | $4.63 | July 11, 2027 | 1,503 | Disposed |
| Jan. 24, 2019 | GYRE | Stock Option (Right to Buy) | Common Stock | $7.97 | Jan. 24, 2029 | 38,000 | Acquired |
| July 30, 2018 | GYRE | Stock Option (Right to Buy) | Common Stock | $9.68 | July 30, 2028 | 25,000 | Acquired |
| March 26, 2018 | GYRE | Stock Option (Right to Buy) | Common Stock | $4.63 | July 11, 2027 | 59 | Disposed |
| Jan. 12, 2018 | GYRE | Stock Option (Right to Buy) | Common Stock | $15.13 | Jan. 12, 2028 | 26,000 | Acquired |
| July 11, 2017 | GYRE | Stock Option (Right to Buy) | Common Stock | $4.63 | July 11, 2027 | 75,000 | Acquired |
| Oct. 22, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock | $4.40 | Oct. 22, 2025 | 28,572 | Acquired |
| Oct. 22, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock | $4.40 | Oct. 22, 2025 | 71,428 | Acquired |
| Oct. 22, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock | $4.40 | Oct. 22, 2025 | 28,572 | Acquired |
| Aug. 20, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock | $6.03 | May 8, 2025 | 14,325 | Acquired |
| Aug. 20, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock | $7.60 | Jan. 22, 2025 | 2,440 | Acquired |
| Aug. 20, 2015 | GYRE | Stock Option (Right to Buy) | Common Stock | $7.60 | Jan. 22, 2025 | 7,320 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2019 | $252,800 | · | · | · | · | · | $2,047 | $471,208 |
| 2018 | $345,301 | $120,855 | · | · | · | · | $2,092 | $969,476 |
| 2017 | $335,244 | $152,536 | · | · | · | · | $2,092 | $779,223 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.